Drugs / LY2811376
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00838084 | Dec 2008 → Jun 2009 | Alzheimer disease | Eli Lilly and Company | Completed | No outcome recorded |
News releases announcing trial results or a regulatory action · 1
| Date | Issuer | Release |
|---|---|---|
| 2014-07-13 | Eli Lilly and Company | Results New Data Shows Combination Therapy is More Effective than Monotherapy in Removing Beta-Amyloid Plaques from the Brains of Mice lilly.com ↗
Data results found that combination therapy was more effective in removing clumps of amyloid-beta protein in the brain - a component that is thought to lead to Alzheimer's disease (AD) - than use of one therapy. |
All press releases naming this drug 1 release
| Date | Issuer | Release |
|---|---|---|
| 2014-07-13 | Eli Lilly and Company | New Data Shows Combination Therapy is More Effective than Monotherapy in Removing Beta-Amyloid Plaques from the Brains of Mice lilly.com ↗ |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | LY2811376 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00838084 ↗ |
| Known as | J3.079.793K | ChEMBL registry synonym — accepted as the source's own label CHEMBL2333941 ↗ |
| Modality | Small molecule | — CHEMBL2333941 ↗ |
| Route | Oral | “Oral capsules” NCT00838084 ↗ |